What’s New in the HPUS and What’s Coming?

This short webinar will present the recent additions and changes to monographs in the HPUS, including revised attenuation levels, updates to quality control methods, and specifications. The status of the ongoing “Technical Gaps” project will also be presented. Additionally, an overview of the HPUS website redesign, which began recently, will be given and attendees will have an opportunity to provide input regarding content and layout changes that will make your use of the pharmacopoeia more efficient and helpful.

FDA’s revised Draft Guidance makes clear the agency’s definition of what is and what is not homeopathic is based on the contents of the HPUS. Don’t be caught with outdated formulations and products as monographs and compendial guidelines are updated. FDA will be comparing your processes and formulas against what is officially included in the HPUS.  This makes it more important than ever for your company to be in-the-know regarding changes and updates in the HPUS.

Attend this half-hour webinar for an overview of these changes, where attendees can receive documents following the webinar that list the monographs affected by these updates.

Whether you manufacture or market homeopathic drug products, the changed information in the HPUS has a bearing on your products’ compliance status. Regulatory and FDA reviews of homeopathic products over the past year support the critical importance of being current with the updates in the HPUS. These changes and updates may affect your business, your cGMP compliance, your products, and your long-term success in the market!